Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Cole Werble
The Medicare Payment Advisory Commission’s annual 2018 report to Congress features the flip side of the recent value-based rhetoric – highlighting “low-value” Medicare purchases. The drug chosen to make that argument is Mallinckrodt’s HP Acthar Gel.